Active surveillance of hepatitis E: a 10-year epidemiological analysis in a city in eastern China

Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study

Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus

Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant

Prevalence of Hepatitis E Virus and Its Associated Outcomes among Pregnant Women in China

Nanoparticle-based multivalent human antibodies offer potent and broad neutralization against Omicron sublineages

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters

Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency

A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity

Epidemiological Features, Risk Factors, and Disease Burden of Respiratory Viruses among Hospitalized Children with Acute Respiratory Tract Infections in Xiamen, China

Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection

Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient

Urine is a viral antigen reservoir in hepatitis E virus infection

An Optimized FI-RSV Vaccine Effectively Protects Cotton Rats and BALB/c Mice without Causing Enhanced Respiratory Disease

A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity

Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron

Molecular Evolution of Attachment Glycoprotein (G) and Fusion Protein (F) Genes of Respiratory Syncytial Virus ON1 and BA9 Strains in Xiamen, China

The Risk of Transfusion-Transmitted Hepatitis E Virus: Evidence from Seroprevalence Screening of Blood Donations

Serological Evidence of Hepatitis E Virus (HEV) Infection Among Ruminant Farmworkers: A Retrospective Study from Malaysia

Epidemiology of Respiratory Pathogens Among Children Hospitalized for Pneumonia in Xiamen: A Retrospective Study

Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans

Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18-45 years enrolled in a clinical trial

Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial

Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent

The study of seroprevalence of hepatitis E virus and an investigation into the lifestyle behaviours of the aborigines in Malaysia

Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study

Viral neutralization by antibody-imposed physical disruption

Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing

Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A

An Optimized High-Throughput Neutralization Assay for Hepatitis E Virus (HEV) Involving Detection of Secreted Porf2

Application of Hepatitis E Virus-Related Markers on Samples from a Developing Country

Vesicular Antibodies: A Bioactive Multifunctional Combination Platform for Targeted Therapeutic Delivery and Cancer Immunotherapy

Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine

An optimized high-throughput fluorescence plate reader-based RSV neutralization assay

Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors

Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection

Development and evaluation of a rapid point-of-care test for detecting the hepatitis E virus antigen

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses

Classification of human and zoonotic group hepatitis E virus (HEV) using antigen detection

Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab

The Bama miniature swine is susceptible to experimental HEV infection

The ORF3 Protein of Genotype 1 Hepatitis E Virus Suppresses TLR3-induced NF-kappa B Signaling via TRADD and RIP1

A high-throughput neutralizing assay for antibodies and sera against hepatitis E virus

A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box

A novel linear neutralizing epitope of hepatitis E virus

Open Reading Frame 3 of Genotype 1 Hepatitis E Virus Inhibits Nuclear Factor-kappa appa B Signaling Induced by Tumor Necrosis Factor-alpha in Human A549 Lung Epithelial Cells

Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

Specific interaction between hnRNP H and HPV16 Li proteins: Implications for late gene auto-regulation enabling rapid viral capsid protein production